Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the category archives: OBN News

Member Company Press Release

Leaf Expression Systems Aids Research into the Novel Coronavirus (SARS-CoV-2, 2019-nCoV) with the Development of Recombinant SARS-CoV-2 N-Protein

Leaf Expression Systems (Leaf), announces that it has developed a recombinant SARS-CoV-2 N-protein (antigen) to aid research into the Novel Coronavirus (SARS-CoV-2, 2019-nCoV) pandemic

Read the rest of entry »

Discovery Park part of domestic and global response to COVID-19 pandemic

Sandwich, Kent, May 13 2020 - The Life sciences and healthcare community at Discovery Park, the Life Sciences Opportunity Zone for ambitious and growing life sciences companies, is working to tackle the coronavirus pandemic in a variety of ways.

Read the rest of entry »

RSSL launches sterility testing service

Reading Scientific Services Ltd (RSSL) has expanded its microbiology capabilities with the launch of a fast, responsive and flexible sterility testing service for pharmaceutical and medical device companies.

Following the opening of its state-of-the-art microbiology laboratory earlier this year, RSSL has launched a sterility testing service in response to sustained client demand and market growth. The move enables the leading contract research organisation (CRO) to further enhance the scope of its biopharmaceutical services and increase testing capacity. 

“Over the last five years, our pharmaceutical analytical services have experienced tremendous growth, so entering the sterility market is a strategically sound step. It builds on our already diverse range of services which, together with our reputation for quality and scientific excellence, is a compelling combination - particularly for clients who are keen to work with one trusted laboratory.  

“Not only that, in addition to a standard 21-day timeframe for this service, we are also offering clients an expedited 16-day and 14-day, which we believe to be one of the one of the quickest available on the market today,” says Reginald Fernandes, microbiology laboratory manager at RSSL.

RSSL’s new service encompasses two sterility test methods; membrane filtration for aqueous, alcohol, solvent and oil-based products, as well as direct inoculation for non-solubles.  Both are used to determine the presence or absence of contaminating micro-organisms in terminally sterilised or aseptic filtered drug products, in accordance with Ph. Eur, JP and USP regulations.  

Its introduction has been facilitated by further investment in a purpose-designed sterility testing suite, featuring a Grade D clean room installed by Connect2Clean rooms with Grade A Bioquell isolators. The new laboratory is expected to be fully operational from February 2020.

“To mark the launch, we are pleased to offer an exclusive cost-saving offer to every client who engages our sterility test services in the first 12 months. We would also like to extend an open invitation to visit our new facilities and discuss how our full-service microbiology offering can help to achieve individual safety goals,” adds Fernandes.

RSSL’s new sterility testing service is part of its comprehensive range of critical assessment services for manufacturers of sterile products. This complete biopharmaceutical testing package also includes microscopy to reduce the risks of particulate contamination, as well as endotoxin to analyse potential pyrogen contamination. 

To find out more about our new sterility testing service or to discuss your sterility testing requirements with one of our specialists please contact us our team on 0118 918 4076 or via enquiries@rssl.com. 

Link to press release on RSSL website: https://www.rssl.com/news-and-events/news/pharmaceutical-and-biopharmaceutical/2019/new-sterility-testing  

 

RSSL named Best CRO at OBN Awards

Outstanding dedication to quality, science and customer service helped Reading Scientific Services Ltd (RSSL) secure Best Contract Research Organisation (CRO) at this year’s OBN Awards.

The scientific consultancy scooped the award for Best CRO by successfully demonstrating the far-reaching impact of its expertise in microbiology, chemistry, biochemistry, microscopy and training; services which have been key to the development, regulatory approval, launch and commercial success of global drug products and medical devices.

Presented with clear evidence of innovation, problem solving and strong relationships with some of the industry’s leading pharmaceutical and biopharmaceutical companies, the judges commended RSSL for the quality of its services and tailored support - with particular recognition given to its out-of-hours, global Emergency Response Service.

Commenting on the award win, Jacinta George, managing director for RSSL said: “We are delighted to receive this acknowledgement at one of the most highly-respected events in the life sciences calendar. We know that the competition was extremely tough, so to be crowned winner of the CRO category is a significant achievement.

"The fact that our analytical Emergency Response Service was highlighted by the judges is particularly gratifying. This unique service - which has already enabled us to solve more than 15,000 emergency incidents ranging from urgent risk assessment of contaminants to potential counterfeit cases - is part of our drive to further improve the customer experience.

"We are exceptionally proud of our life-changing science and results, so recognition from our peers in the form of this OBN award helps to strengthen our resolve to raise the bar even higher.”

Judged by an independent panel of industry experts, the OBN Awards celebrates the most inspiring and innovative UK-based companies across biotech, medtech, imaging, digital and synthetic biology. This year’s awards evening was held at the Examination Schools in Central Oxford and attended by around 250 guests from across the life sciences industry.

Like what you've heard? Visit the RSSL careers pages here to discover some of our current exciting job opportunities.

Mary Ann Liebert Publishers: PHAGE: Therapy, Applications, and Research

The only peer-reviewed journal dedicated to bacteriophage research and its applications in medicine, agriculture, aquaculture, veterinary applications, animal production, food safety, and food production.

Read the rest of entry »

CHAIN Biotechnology: Cancer vaccine firm Oxford Vacmedix announces collaboration and Innovate UK grant

Oxford Vacmedix UK Limited (OVM), the UK-based biopharma company focused on the development of cancer vaccines, announced today the award of an Innovate UK grant to CHAIN Biotechnology Ltd (CHAIN) and the University of Oxford to develop live biotherapeutics that support oral delivery for OVM’s recombinant overlapping peptide (ROP) cancer vaccines.

Read the rest of entry »

Leaf Expression Systems Launch First Line of Hypertrans® Research Products

29 May 2019: Norwich, UK Leaf Expression Systems, a contract development and manufacturing organisation specialising in the plant-based expression and production of proteins, vaccines, metabolites and complex natural proteins, has announced the launch of its online list of products available for purchase by researchers working within the life sciences and agricultural industries.

Read the rest of entry »

Leaf Expression Systems Ltd: Plant Bioscience Ltd transfers control of Hypertrans® plant-based biologics and vaccines expression technology to Leaf Expression Systems Ltd

14 May 2019: Norwich Plant Bioscience Ltd (PBL) and Leaf Expression Systems Ltd (Leaf) are delighted to announce a further development in their relationship, with PBL granting Leaf the exclusive rights to sub-license the Hypertrans® transient expression system, the core technology underpinning Leaf’s biologics and vaccines contract development and manufacturing services business.

Read the rest of entry »

World Courier: White Paper: Logistics by Design - a Framework for Advanced Therapy Developers

The Logistics by Design white paper uses a risk based framework that identifies areas within your supply chain that need to be addressed at the earliest possible moment.

Read the rest of entry »

Blue Earth Diagnostics Announces Addition of Axumin® (fluciclovine (18F)) to EAU Guidelines for imaging in patients with biochemical recurrence in Prostate Cancer

Oxford, UK – April 16, 2019 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that Axumin (fluciclovine (18F)) has recently been added to the European Association of Urology (EAU) 2019 Clinical Practice Guidelines in Oncology for Prostate Cancer (PCa).

Read the rest of entry »

Pages: Previous12NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.